A significant discovery in cancer research is emerging with the use of VHH fragments to reactivate dysfunctional p53. This essential cancer inhibitor protein is frequently inactivated in several forms of malignancies, https://www.zenhealths.com/p53-reactivation-nanobody-cancer-research